TMEM33 knockdown cells exhibit reduced tumor aggressiveness in vivo, as evidenced by the decreased tumor weight and volume in the subcutaneous injection model, and they decreased the number of metastatic nodules in the lungs in the tail vein injection model [115]. This evidence concerns the gene TMEM33 and neoplasm.